CSIMarket Company Name, Ticker, Competitors, else..
COVIDIEN LTD.  (COV)
Other Ticker:  
 
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 458
 Employees 39,500
 Revenues (TTM) (Millions $) 10,706
 Net Income (TTM) (Millions $) 1,775
 Cash Flow (TTM) (Millions $) 237
 Capital Exp. (TTM) (Millions $) 352

Covidien Ltd.
We are a global leader in the development, manufacture and sale of healthcare products for use in clinical and home settings. Our products are found in almost every hospital in the United States, and we have a significant and growing presence in non-U.S. markets. Our mission is to create and deliver innovative healthcare solutions, developed in collaboration with medical professionals, which enhance the quality of life for patients and improve outcomes for our customers and our shareholders.


   


Customers Net Income fell by COV's Customers Net Profit Margin fell to

-18.51 %
3.15 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BDX   -1.37%    
MDT   -5.01%    
PDCO   -5.15%    
BSX   -1.17%    
SYK   -1.81%    
MCK   -2.86%    
• View Complete Report
   



Envveno Medical Corporation

Envveno Medical Corporation announced fiscal period ending Sep 30 2021 operating loss of $-2.706531 millions

In the fiscal period ending Sep 30 2021 Envveno Medical Corporation decreased loss of $-0.26 per share compared to $-1.50 a year ago and improved from $-0.28 per share from the previous quarter.

Envveno Medical Corporation reported operating deficit of $-2.706531 millions, in the fiscal period ending Sep 30 2021, a deterioration from the operating loss of $-1.922287 millions, realized in third quarter of 2020

Credex Corporation

Credex Corporation announced third quarter of 2021 earnings season operating shortfall of $-0.002579 millions

Credex Corporation announced operating shortfall of $-0.002579 millions, in the third quarter of 2021 earnings season, a change from the operating shortfall of $-0.00135 millions, recorded in the same quarter a year ago.


Lifemd Inc

Lifemd Inc announced financial period ending Sep 30 2021 operating loss of $-12.591304 millions

Lifemd Inc announced earnings per share of $-0.54 and Sales of $22.31 millions in the financial period ending Sep 30 2021, Company's decreased loss per share, versus $-1.65 eps, earned in the same quarter a year ago, although Lifemd Inc saw its Sales rise by 126.67% in the same period.

compared to previous quarter improved from $-0.64 per share and Sales advanced by 11.8 % from $22.31 millions.

Ballantyne Strong Inc

Ballantyne Strong Inc announced financial period ending Sep 30 2021 operating loss of $-0.118 millions

In the financial period ending Sep 30 2021 Ballantyne Strong Inc eps remained unchanged of $0.38 per share compared to $0.38 a year ago and EPS turn positive from $-0.02 per share from the previous quarter.

Sales faded by -38.27% to $6.12 millions from $9.91 millions in the same quarter a year ago and sequentially Sales increased by 0.36 % from $6.09 millions.

Imac Holdings Inc

Redemption of Losses, Modest Revenue Increase

Imac Holdings Inc announced earnings per share of $-0.07 and Sales of $3.47 millions in the fiscal third quarter of 2021, Company's decreased loss per share, versus $-0.12 eps, earned in the same quarter a year ago, although Imac Holdings Inc saw its Sales rise by 0.28% in the same period.

In comparison to previous quarter improved from $-0.08 per share and Sales increased by 0.63 % from $3.47 millions.






 

Covidien Ltd.'s Segments
 
Medical Devices
 Segment    84.81 % of total Revenue
Advanced Surgical
 Segment    34.55 % of total Revenue
General Surgical
 Segment    14.33 % of total Revenue
Total Surgical Solutions
 Segment    48.88 % of total Revenue
Airway & Ventilation Products
 Segment    6.18 % of total Revenue
Patient Monitoring
 Segment    9.34 % of total Revenue
Nursing Care
 Segment    9.57 % of total Revenue
Patient Care
 Segment    10.09 % of total Revenue
Total Respiratory Patient Care
 Segment    35.18 % of total Revenue
Peripheral Vascular
 Segment    11.47 % of total Revenue
Neurovascular
 Segment    4.47 % of total Revenue
Total Vascular Therapies
 Segment    15.93 % of total Revenue
Medical Supplies
 Segment    15.19 % of total Revenue
 
• View Complete Report
  Company Estimates  
  • Revenue Outlook
Covidien Ltd. does not provide revenue guidance.

• Earnings Outlook
Imac Holdings Inc does not provide earnings estimates.

 
Geographic Revenue Dispersion
United States 49.57 %
Non U.S. Developed Markets 35.03 %
Emerging Markets 15.4 %


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

 Stocks


Event Calendar

ASYS's Profile

Stock Price

ASYS's Financials

Business Description

Fundamentals

Charts & Quotes

ASYS's News

Suppliers

ASYS's Competitors

Customers & Markets

Economic Indicators

ASYS's Growth

Company Segments

 Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness
Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

 Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies
Help


Sitemap

Advertise

About us

 Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071